SA

Saba Anjum

Active Director Director DIN 09558473
DIN 09558473 First appointment Apr 2022 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Apr 2022
Shareholding value Locked Premium profile

About Saba Anjum

Data last updated:

Saba Anjum has 4 years in corporate governance. Holds Director role. Currently with 1 company, including Wonderful Biotech Private Limited. Engaged in Technology. Contributes to corporate operations.

DIN 09558473
Primary Designation Director
First Appointment 01 Apr 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedStatus
Wonderful Biotech Private Limited U24303DL2022PTC396040
Director01 Apr 20222022Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Wonderful Biotech Private Limited
Premium access

Shareholding and investment profile for Saba Anjum

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Saba Anjum

Saba Anjum has 4 years in corporate governance. Holds Director role. Currently with 1 company, including Wonderful Biotech Private Limited. Engaged in Technology. Contributes to corporate operations.

Saba Anjum is associated with 1 company as Director.

Saba Anjum has expertise in Technology.

Saba Anjum has 4 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available